Pathology, Idiopathic pulmonary fibrosis, Internal medicine, Lung and Lung cancer are his primary areas of study. His Pathology research is multidisciplinary, incorporating perspectives in Respiratory disease and Stage classification. The concepts of his Idiopathic pulmonary fibrosis study are interwoven with issues in Pulmonary fibrosis, FEV1/FVC ratio and Intensive care medicine.
The study incorporates disciplines such as Gastroenterology, Placebo, Surgery and Oncology in addition to Internal medicine. The various areas that Andrew G. Nicholson examines in his Lung study include Differential diagnosis and Biopsy, Radiology. His Lung cancer research includes elements of Stage, Carcinoma, Metastasis and Adenocarcinoma.
His main research concerns Pathology, Internal medicine, Lung, Lung cancer and Radiology. Andrew G. Nicholson interconnects Interstitial lung disease, Respiratory disease, Idiopathic pulmonary fibrosis and Adenocarcinoma in the investigation of issues within Pathology. Andrew G. Nicholson combines subjects such as Fibrosis and Pulmonary fibrosis with his study of Idiopathic pulmonary fibrosis.
Andrew G. Nicholson has included themes like Gastroenterology, Surgery, Oncology and Cardiology in his Internal medicine study. His Immunology research extends to the thematically linked field of Lung. The Lung cancer study which covers Carcinoma that intersects with Immunohistochemistry.
His primary scientific interests are in Internal medicine, Lung, Lung cancer, Pathology and Interstitial lung disease. His studies deal with areas such as Gastroenterology, Intensive care and Oncology as well as Internal medicine. His Lung study which covers Immunology that intersects with Idiopathic pulmonary fibrosis.
Andrew G. Nicholson has included themes like Pembrolizumab, Clinical trial and Radiology in his Lung cancer study. Andrew G. Nicholson combines subjects such as Stage, Airway and Adenocarcinoma with his study of Pathology. Andrew G. Nicholson has researched Interstitial lung disease in several fields, including Disease, Pediatrics, Parenchyma and Lung biopsy.
The scientist’s investigation covers issues in Lung cancer, Lung, Internal medicine, Pathology and Clinical trial. His biological study deals with issues like Lymph node, which deal with fields such as Perioperative, Thymoma, Dissection and Cancer. His Lung study integrates concerns from other disciplines, such as Mediastinum, Malignancy and Early onset.
His research brings together the fields of Oncology and Internal medicine. His Pathology study focuses on Immunohistochemistry in particular. His research on Clinical trial also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutations of the BRAF gene in human cancer
Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens.
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson.
Journal of Thoracic Oncology (2011)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman;Philip Stephens;Raffaella Smith;Gillian L. Dalgliesh.
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma.
The New England Journal of Medicine (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis;Elisabeth Brambilla;Andrew G. Nicholson;Yasushi Yatabe.
Journal of Thoracic Oncology (2015)
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.
William D. Travis;Elisabeth Brambilla;Allen P. Burke;Alexander Marx.
Journal of Thoracic Oncology (2015)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta.
Journal of Thoracic Oncology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: